Search

Search Results

• 

  Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

  F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro

  208-214

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.756

  2940

  PDF: 1614
• 

  Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices

  F.M. Perrotta, A. Scarno, A. Carboni, V. Bernardo, M. Montepaone, E. Lubrano, A. Spadaro

  105-112

  23-07-2013

  https://doi.org/10.4081/reumatismo.2013.105

  3273

  PDF: 1204
• 

  RETRACTED - Pain in systemic sclerosis

  S. Stisi, P. Sarzi-Puttini, M. Benucci, G. Biasi, S. Bellissimo, R. Talotta, F. Atzeni

  44-47

  06-06-2014

  https://doi.org/10.4081/reumatismo.2014.764

  2200

  PDF: 1224
• 

  Chronic widespread pain in spondyloarthritis

  F. Atzeni, L. Boccassini, M. Di Franco, A. Alciati, A. Marsico, M. Cazzola, G. Cassisi, P. Sarzi-Puttini

  28-32

  06-06-2014

  https://doi.org/10.4081/reumatismo.2014.761

  3069

  PDF: 1751

• Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis

  F. Salaffi, A. Stancati, A. Silvestri, M. Carotti, W. Grassi

  161-173

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.161

  2612

  PDF: 2761
• 

  Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

  Ebru Yılmaz, Özge Pasin

  28-10-2024

  https://doi.org/10.4081/reumatismo.2024.1709

  44363

  PDF: 783

• PO:02:021 | Sustained Improvements with Bimekizumab in Pain, Morning Stiffness, Fatigue, Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 3-Year Results from Two Phase 3 Studies Victoria Navarro-Compán¹, Uta Kiltz^2|3, Philip J Mease⁴, Maureen Dubreuil⁵, Karl Gaffney⁶, Atul Deodhar⁷, Christine De La Loge⁸, Diana Voiniciuc⁹, Jason Coarse¹⁰, Ilaria Spadafora¹¹, Helena Marzo-Ortega¹² | ¹La Paz University Hospital, IdiPaz, Department of Rheumatology Madrid Spain; ²Ruhr-University Bochum Bochum Germany; ³Rheumazentrum Ruhrgebiet Herne, Germany; ⁴Department of Rheumatology, Swedish Medical Center and Providence St. Joseph Health and University of Washington Seattle, USA; ⁵Boston University School of Medicine, Department of Rheumatology Boston, USA; ⁶Norfolk and Norwich University Hospital NHS Trust, Department of Rheumatology Norfolk, United Kingdom; ⁷Oregon Health and Science University, Division of Arthritis and Rheumatic Diseases Portland, USA; ⁸UCB Brussels, Belgium; ⁹UCB Slough, United Kingdom; ¹⁰UCB Morrisville, USA; ¹¹UCB Milan, Italy; ¹²NIHR Leeds Biomedical Research Centre, University of Leeds Leeds, United Kingdom

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2284

  27
• 

  Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

  Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

  27-01-2025

  https://doi.org/10.4081/reumatismo.2025.1694

  2593

  PDF: 403